Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 34.33% vs 31.19% in Sep 2024
Standalone Net Profit
YoY Growth in quarter ended Sep 2025 is 127.87% vs 8.38% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 60.33% vs 45.21% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 45.57% vs 83.10% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Fredun Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 20.26% vs -27.83% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 34.33% vs 31.19% in Sep 2024
Quarterly - Standalone Net Profit
QoQ Growth in quarter ended Sep 2025 is 43.72% vs -4.24% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 127.87% vs 8.38% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 31.55% vs -2.58% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 60.33% vs 45.21% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 18.38% vs -19.88% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 45.57% vs 83.10% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






